Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Chloroguanabenz . acetate
80
CHF
CHF 80.00
In stock
AG-MR-C0036-M0011 mgCHF 80.00
AG-MR-C0036-M0055 mgCHF 320.00
Product Details | |
---|---|
Synonyms | 1-[(E)-2,3,6-Trichlorophenylmethyleneamino]guanidine; Hydrazinecarboximidamide, 2-[(2,3,6-trichlorophenyl)methylene]-; Guanabenz; Chlorine-Guanabenz |
Product Type | Chemical |
Properties | |
Formula |
C8H7Cl3N4 . C2H4O2 |
MW | 265.5 . 60.1 |
CAS | 23113-55-5 |
Purity Chemicals | ≥95% (NMR) |
Appearance | White to off-white powder. |
Solubility | Soluble in DMSO or ethanol. |
Reconstitution | Stock solutions can be made up to 10mM in DMSO. |
Identity | Determined by 1H-NMR. |
InChi Key | DFBSKPLTAXXMPH-LAJPFITQSA-M |
Smiles | CC(=N)N\N=C\C1=C(Cl)C=CC(Cl)=C1Cl |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | After reconstitution, prepare aliquots and store at -20°C. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Antiprion agent.
- Inhibitor of protein aggregation.
- Specifically reduces accumulation of a pathogenic fragment of Huntingtin in a transiently transfected cellular model of Huntington’s disease (HD).
- Tool for treating HD and other polyglutamine expansion associated diseases.
Product References
- Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions: D. Tribouillard-Tanvier, et al.; PLoS One 3, e1981 (2008)
- Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases: A. Bertolotti & M. Blondel; Patent WO002008041133A2 (2008)
- Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography: F. Gug, et al.; Bioconjug. Chem. 21, 279 (2010)